RITSUKO KOMAKI to Mutagenicity Tests
This is a "connection" page, showing publications RITSUKO KOMAKI has written about Mutagenicity Tests.
Connection Strength
0.249
-
Mutagen sensitivity may predict lung protection by amifostine for patients with locally advanced non-small cell lung cancer treated by chemoradiotherapy. Semin Oncol. 2005 Apr; 32(2 Suppl 3):S92-8.
Score: 0.249